By Purity :

The purity segment is categorized into above 99%, 99%, and less than 99%. In 2022, the pharmaceutical intermediate 99% segment accounted for the highest market share of 45.05% in the overall N-bromosuccinimide market. The 99% purity of N-Bromosuccinimide is majorly utilized in the production of pharmaceuticals, chemicals, and other products. Furthermore, 99% ensures superior properties such as neutral and organic which are beneficial for the production of pharmaceutical drugs. For instance, according to the 14th Five Year Plan in China (2021-2025), emphasis is given to the pharmaceutical industry supply security, encouraging the international organization to set up their pharmaceutical manufacturing facilities in China, and others. Hence, the pharmaceutical production growth in China is accelerating the adoption of 99% N-Bromosuccinimide to ensure effective organic synthetics. This factor is leading to market growth.

Furthermore, above 99% is expected to be the fastest-growing segment in the market over the forecast period. This is due to the increasing demand for superior purity materials for the production of chemical products.

Get More Information

Download Sample Report

By Application :

The application segment is categorized into organic synthesis, pharmaceutical intermediates, insecticidal agent, and others. In 2022, the pharmaceutical intermediates segment accounted for the highest market share in the N-Bromosuccinimide market. N-Bromosuccinimide is equipped with various beneficial characteristics, including superior purity, and higher melting point. These vital characteristics ensure superior synthesis in pharmaceutical intermediates. For instance, according to India Brand Equity Foundation (IBEF), in the year 2020, the pharmaceuticals market in India was valued at USD 42.0 billion, and by the year 2024, it is projected at USD 65.0 billion, an increase of 54.8%. Hence, the increasing deployment of N-Bromosuccinimide in pharmaceutical intermediates is augmenting market growth.

However, organic synthesis is expected to be the fastest-growing segment during the forecast period because the development of new chemicals is increasing. This, in turn, is fostering organic synthesis, and as a result, the demand for N-Bromosuccinimide is increasing.

By End-use Industry :

The end-use industry segment is categorized into chemical industry, pharmaceutical industry, and others. In 2022, the pharmaceutical industry segment accounted for the highest market share in the N-Bromosuccinimide market. N-Bromosuccinimide is an easier-to-handle and safer brominating agent as compared with bromine. As a result, N-Bromosuccinimide is primarily deployed in the manufacturing of tablets and other forms of pharmaceutical drugs. The rising pharmaceutical production activities are due to increasing government initiatives, and new facility developments, among others. For instance, according to IQVIA, a leading pharmaceutical manufacturer in the U.S., the pharmaceutical industry in the U.S. registered a growth of 5.6% from 2016 to 2021. Thus, the surge in production activities associated with pharmaceuticals is expected to drive market growth

However, the chemical segment is expected to be the fastest-growing segment in the N-Bromosuccinimide market during the forecast period. This is due to the increasing focus on the development of new advanced chemical manufacturing plants, and government initiatives, among others.

By Region :

The regional segment includes North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.

In 2022, Asia Pacific accounted for the highest market share at 39.05% and was valued at USD 7.63 million, and is expected to reach USD 8.31 million in 2030. In Asia Pacific, China accounted for the highest market share of 40.75% during the base year of 2022. The booming pharmaceutical production in the Asia Pacific region is expected to foster the adoption of N-Bromosuccinimide, which will accelerate the market growth in the region. For instance, according to the General Statistics Office of Vietnam, the total medicines output in Vietnam in 2019 was USD 3255.6 million, and in 2020 it was USD 3484.5 million, a rise of 7.03%. Henceforth, the rising pharmaceutical production in the Asia Pacific region is anticipated to accelerate the N-Bromosuccinimide market growth.

Furthermore, North America is expected to witness significant growth over the forecast period. This is attributed to the growing demand for superior synthesis chemicals. Therefore, the adoption of N-Bromosuccinimide is increasing in North American industries such as pharmaceuticals, and fine chemicals, among others. This factor is proliferating the N-Bromosuccinimide market growth in North America.